PacBio announced a key study published in the American Journal of Human Genetics by Radboud University Medical Center, showcasing the effectiveness of its HiFi long-read sequencing technology for ...

PacBio announced its involvement in a groundbreaking study published in Nature Genetics, which utilized its advanced sequencing technology to explore the genetic basis of a rare Mendelian condition in ...

The HiFi Solves Sub-fertility Consortium in Asia Pacific was launched at PRISM Asia 2024 to advance long-read sequencing in reproductive genomics. Its first major findings will now be presented at ...

MENLO PARK, Calif., March 18, 2026 (GLOBE NEWSWIRE) -- PacBio (PACB), a leading provider of high-quality, long-read sequencing technologies, today announced that Basecamp Research, a frontier AI lab ...

MENLO PARK, Calif., Oct. 31, 2023 /PRNewswire/ -- PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, today announced it has begun taking orders for its ...

MENLO PARK, Calif., Sept. 22, 2025 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, today announced its entry into the ...

On May 7, 2026, Pacific Biosciences of California, Inc. (NASDAQ:PACB) reported Q1 EPS of (12c), versus the consensus estimate ...

PacBio aims to dive deeper into the family planning market with an updated carrier screening kit designed to take multiple DNA tests that check parents for specific genes and combine them into a ...

Q1 2026 Management view "Our first quarter of 2026 was highlighted by record consumable revenue, greater than 100% year-over-year growth in consumable shipments to clinically focused accounts and ...

Pacific Biosciences of California Inc. (NASDAQ:PACB) on Wednesday announced preliminary revenue of $36.9 million versus a consensus of $33.49 million. The company said the first quarter met ...